Terms: = Colorectal cancer AND RNF43, DKFZp781H02126, 54894, Q68DV7, URCC, RNF124, MGC125630, FLJ20315, DKFZp781H0392 AND Prognosis
19 results:
1. DNA Mutational Profiling in Patients With colorectal cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations.
Innocenti F; Mu W; Qu X; Ou FS; Kabbarah O; Blanke CD; Venook AP; Lenz HJ; Rashid NU
J Clin Oncol; 2024 Feb; 42(4):399-409. PubMed ID: 37992266
[TBL] [Abstract] [Full Text] [Related]
2. Treatment of
Ros J; Rodríguez-Castells M; Saoudi N; Baraibar I; Salva F; Tabernero J; Élez E
Expert Rev Anticancer Ther; 2023; 23(8):797-806. PubMed ID: 37482749
[TBL] [Abstract] [Full Text] [Related]
3. Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer.
Huang W; Li W; Xu N; Li H; Zhang Z; Zhang X; He T; Yao J; Xu M; He Q; Guo L; Zhang S
Cancer Med; 2023 May; 12(9):10187-10198. PubMed ID: 37096801
[TBL] [Abstract] [Full Text] [Related]
4. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
5. Exome sequencing revealed comparable frequencies of rnf43 and BRAF mutations in Middle Eastern colorectal cancer.
Siraj AK; Bu R; Masoodi T; Parvathareddy SK; Iqbal K; Al-Haqawi W; Al-Dossari H; Azam S; Qadri Z; Annaiyappanaidu P; Al-Dayel F; Al-Kuraya KS
Sci Rep; 2022 Jul; 12(1):13098. PubMed ID: 35907983
[TBL] [Abstract] [Full Text] [Related]
6. Patients deriving long-term benefit from immune checkpoint inhibitors demonstrate conserved patterns of site-specific mutations.
Principe DR
Sci Rep; 2022 Jul; 12(1):11490. PubMed ID: 35798829
[TBL] [Abstract] [Full Text] [Related]
7. Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon cancer Predicts a Poor prognosis.
Wu T; Zhang X; Xing L; Pan D; Liu P; Ding R; Yang R; Yang X; Li Y
Dis Markers; 2022; 2022():5883101. PubMed ID: 35677634
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological and Molecular Characteristics of colorectal Signet Ring Cell Carcinoma: A Review.
An Y; Zhou J; Lin G; Wu H; Cong L; Li Y; Qiu X; Shi W
Pathol Oncol Res; 2021; 27():1609859. PubMed ID: 34381313
[TBL] [Abstract] [Full Text] [Related]
9. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated colorectal cancer.
Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
[TBL] [Abstract] [Full Text] [Related]
11. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY
Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with colorectal cancer.
Salem ME; Battaglin F; Goldberg RM; Puccini A; Shields AF; Arguello D; Korn WM; Marshall JL; Grothey A; Lenz HJ
Oncologist; 2020 May; 25(5):404-413. PubMed ID: 31848314
[TBL] [Abstract] [Full Text] [Related]
13. Reduced Frequency and Prognostic Significance of Ring Finger Protein 43 Nucleotide Polymorphisms in a Chinese colorectal cancer Cohort.
Wen D; Wang G; Huang Z; Cui X; Song J; Zhu Z; Cui L
DNA Cell Biol; 2019 Jun; 38(6):541-548. PubMed ID: 31140864
[TBL] [Abstract] [Full Text] [Related]
14. Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High colorectal cancers.
Sato K; Kawazu M; Yamamoto Y; Ueno T; Kojima S; Nagae G; Abe H; Soda M; Oga T; Kohsaka S; Sai E; Yamashita Y; Iinuma H; Fukayama M; Aburatani H; Watanabe T; Mano H
Clin Cancer Res; 2019 Jan; 25(1):378-389. PubMed ID: 30279230
[TBL] [Abstract] [Full Text] [Related]
15. ALK, ROS1, and NTRK Rearrangements in Metastatic colorectal cancer.
Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Tejpar S; Sartore-Bianchi A; Hechtman JF; Christiansen J; Novara L; Tebbutt N; Fucà G; Antoniotti C; Kim ST; Murphy D; Berenato R; Morano F; Sun J; Min B; Stephens PJ; Chen M; Lazzari L; Miller VA; Shoemaker R; Amatu A; Milione M; Ross JS; Siena S; Bardelli A; Ali SM; Falcone A; de Braud F; Cremolini C
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29370427
[TBL] [Abstract] [Full Text] [Related]
16. Clinical Sequencing Defines the Genomic Landscape of Metastatic colorectal cancer.
Yaeger R; Chatila WK; Lipsyc MD; Hechtman JF; Cercek A; Sanchez-Vega F; Jayakumaran G; Middha S; Zehir A; Donoghue MTA; You D; Viale A; Kemeny N; Segal NH; Stadler ZK; Varghese AM; Kundra R; Gao J; Syed A; Hyman DM; Vakiani E; Rosen N; Taylor BS; Ladanyi M; Berger MF; Solit DB; Shia J; Saltz L; Schultz N
Cancer Cell; 2018 Jan; 33(1):125-136.e3. PubMed ID: 29316426
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological significance and prognostic value of Wilms' tumor gene expression in colorectal cancer.
Miyata Y; Kumagai K; Nagaoka T; Kitaura K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
Cancer Biomark; 2015; 15(6):789-97. PubMed ID: 26406403
[TBL] [Abstract] [Full Text] [Related]
18. Downregulation of ring-finger protein 43 in glioma associates with poor prognosis.
Xi S; Zhang X; Chen H; Zhong Z; Lu J; Hu W; Wu Q; Zeng J
Int J Clin Exp Pathol; 2015; 8(1):490-6. PubMed ID: 25755738
[TBL] [Abstract] [Full Text] [Related]
19. A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome.
Hazama S; Nakamura Y; Takenouchi H; Suzuki N; Tsunedomi R; Inoue Y; Tokuhisa Y; Iizuka N; Yoshino S; Takeda K; Shinozaki H; Kamiya A; Furukawa H; Oka M
J Transl Med; 2014 Mar; 12():63. PubMed ID: 24612787
[TBL] [Abstract] [Full Text] [Related]
